Investment Banking Overview
Brookline Capital Markets' investment banking team provides financing solutions and strategic advice to promising life sciences, medical technology and diagnostics companies in both the public and private markets, as well as to Special Purpose Acquisition Companies ("SPACs") and other emerging growth enterprises.
Brookline prides itself on its ability to partner with its private corporate clients from inception to IPO and has established a strong reputation in the pre-IPO healthcare investment banking arena. Over the past several years, we have greatly expanded its public investment banking team, adding resources, capabilities and senior team members that now underpin our comprehensive suite of investment banking services. With the growth of its public investment banking franchise and the continued success of its market-leading private placement platform, Brookline stands ready to provide value-added investment banking advice, analysis, and execution for its healthcare corporate clients at any point of clinical development or financial maturity.
In addition, Brookline differentiates itself through its ability to source capital from traditional institutional investors, as well from its expansive, proprietary network of sophisticated high net worth individual investors and hard-to-access family office funds. Brookline's investor network provides its corporate clients access to a source of long-term capital from committed, patient, and fundamental investors. Over the course of its evolution, Brookline has developed a rigorous due diligence process that has resulted directly in success for its corporate clients and for its proprietary investor network, leading to the Firm's reputation as a "curator" of compelling life sciences, medical technology and diagnostics investments.
Brookline's senior leadership has a robust history of executing public and private investment banking transactions for healthcare clients across a variety of indications and stages of development, resulting in a distinguished track record of success. In addition, over the course of their careers, members of the team have completed hundreds of assignments for emerging growth equity enterprises in other industries.
The team has completed over 100 transactions for its clients, raising over $3.2 billion, and continues to build and maintain its reputation as one of the premier investment banking boutiques on Wall Street.